Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Desoximetasone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for desoximetasone and what is the scope of freedom to operate?

is the generic ingredient in three branded drugs marketed by Teligent Pharma Inc, Taro, Lupin Atlantis, Akorn, Taro Pharms North, Perrigo New York, Glenmark Generics, Altana, G And W Labs Inc, Perrigo Israel, Fougera Pharms, Actavis Mid Atlantic, Groupe Parima Inc, and Novel Labs Inc, and is included in thirty-three NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desoximetasone has four patent family members in four countries.

There are seven drug master file entries for desoximetasone. Fifteen suppliers are listed for this compound.

Summary for Generic Name: desoximetasone

Drug Master File Entries: see list7
Suppliers / Packagers: see list15
Bulk Api Vendors: see list22
Clinical Trials: see list2
Patent Applications: see list5,601
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Drug Prices:see low prices
DailyMed Link:desoximetasone at DailyMed

Pharmacology for Ingredient: desoximetasone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Groupe Parima Inc
GEL;TOPICAL204675-001Aug 12, 2016ABRXNoNo► Subscribe► Subscribe
Teligent Pharma Inc
OINTMENT;TOPICAL208101-001Feb 25, 2016ABRXNoNo► Subscribe► Subscribe
G And W Labs Inc
OINTMENT;TOPICAL206740-001Dec 23, 2016ABRXNoNo► Subscribe► Subscribe
Fougera Pharms
OINTMENT;TOPICAL078657-001Sep 28, 2012ABRXNoNo► Subscribe► Subscribe
SPRAY;TOPICAL204141-001Apr 11, 2013ATRXYesYes5,990,100► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus